Opportunity Information: Apply for TI 15 013
Apply for TI 15 013
- The Substance Abuse Mental Health Services Adminis. in the health sector is offering a public funding opportunity titled "Program Supplements for Violence Intervention to Enhance Lives (VITEL)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243 Substance Abuse and Mental Health ServicesProjects of Regional and National Significance.
- This funding opportunity was created on Apr 21, 2015 and posted on Apr 21, 2015.
- Applicants must submit their applications by Jun 22, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $350,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $70,000.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility for this funding opportunity is limited to current SAMHSA FY 2013 TCE HIV Minority Women grantees because these grants specifically focus on minority women who are disproportionately affected by intimate partner violence. These grantees have the established infrastructure, partnerships, and necessary knowledge and skills to rapidly implement the Violence Intervention to Enhance Lives program without a lengthy start up period or break in service.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Program Supplements for Violence Intervention to Enhance Lives (VITEL) (Funding Opportunity Number TI 15 013) is a SAMHSA discretionary grant that offered one year of supplemental funding to a small set of existing projects to strengthen and expand services already required under an earlier SAMHSA initiative. Instead of funding brand-new programs, VITEL was designed as an add-on to help current grantees deepen their work quickly and without disrupting ongoing treatment services. The supplement focuses on adding intimate partner violence (IPV) screening into existing substance use disorder (SUD) treatment settings, recognizing that IPV is closely tied to substance use, health risk behaviors, and barriers to care, particularly among minority women affected by or at risk for HIV.
Eligibility was intentionally narrow. Only organizations that were already funded in FY 2013 under the Targeted Capacity Expansion (TCE) Substance Abuse Treatment for Racial/Ethnic Minority Women at High Risk for HIV/AIDS program (often referenced as the TCE HIV Minority Women cohort; original announcement TI 13 011) could apply. SAMHSA limited eligibility to these grantees because they already served the population most affected by the intersecting issues VITEL targets and because they already had the infrastructure, partnerships, and clinical capacity needed to implement IPV screening rapidly, without a long start-up period or a break in services.
The population of focus for the underlying TCE HIV Minority Women program, and therefore for these supplements, is African American, Hispanic/Latina, and other racial/ethnic minority women ages 18 and older who have SUDs and/or co-occurring substance use and mental disorders and who are living with HIV/AIDS or at risk for HIV/AIDS. The program also explicitly encompassed women across sexual orientations (heterosexual, lesbian, and bisexual), women who were previously incarcerated, and their significant others. VITEL builds on that foundation by addressing IPV as a major factor that can worsen substance use, increase HIV risk, and impede consistent engagement in treatment and support services.
VITELs core service expansion was the implementation of IPV screening within behavioral health and SUD treatment services, paired with appropriate referrals. While the announcement centers on screening, the practical intent is broader: identify IPV early and connect clients to services and supports that can reduce harm, improve safety, and remove barriers to treatment adherence and health care engagement. The supplements were funded by the Secretarys Minority AIDS Initiative Fund (SMAIF), reflecting the federal priority of reducing HIV-related disparities and improving outcomes in communities that are disproportionately affected.
The program laid out five overarching goals: (1) reduce IPV through screening and referrals, (2) reduce risky behaviors that contribute to new HIV infections and substance use disorders, (3) increase access to care and improve health outcomes for people living with HIV and AIDS, (4) reduce HIV-related health disparities linked to IPV by implementing an IPV screening tool, and (5) assess the real-world feasibility of integrating IPV screening into behavioral health settings. Taken together, these goals emphasize both immediate client-level impact (screening, referral, improved access and outcomes) and system-level learning (whether and how IPV screening can be sustained and scaled in treatment environments).
Funding details show this was a small, targeted supplement competition. SAMHSA expected to make 5 awards with an estimated total funding of $350,000. The award ceiling was $70,000 for the one-year supplement period, and there was no cost sharing or matching requirement. The assistance listing was CFDA 93.243 (Substance Abuse and Mental Health Services Projects of Regional and National Significance). The opportunity was posted April 21, 2015, with an application closing date of June 22, 2015, and it was archived July 22, 2015. For administrative or access issues related to the full announcement, the listed contact was Eileen Bermudez in SAMHSAs Division of Grants Management.
Frequently Asked Questions (FAQs)
What is the VITEL program supplement opportunity (TI 15 013)?
Program Supplements for Violence Intervention to Enhance Lives (VITEL) (Funding Opportunity Number TI 15 013) was a SAMHSA discretionary grant opportunity that provided one year of supplemental funding to a limited set of existing SAMHSA-funded projects. It was designed to strengthen and expand services already required under an earlier SAMHSA initiative, rather than fund brand-new programs.
Is VITEL intended to fund new programs?
No. VITEL was specifically structured as an add-on (supplement) to support current grantees in deepening their work quickly, without disrupting ongoing substance use disorder (SUD) treatment services.
What is the main service expansion supported by VITEL?
The core service expansion is implementing intimate partner violence (IPV) screening within existing behavioral health and SUD treatment settings, along with appropriate referrals. While the announcement emphasizes screening, the practical intent is to identify IPV early and connect clients to services and supports that improve safety and reduce barriers to treatment and health care engagement.
Why does the supplement focus on intimate partner violence (IPV) in SUD treatment settings?
The opportunity recognizes that IPV is closely tied to substance use, health risk behaviors, and barriers to care, particularly among minority women affected by or at risk for HIV. Addressing IPV through screening and referrals is intended to reduce harm and improve engagement in treatment and related health services.
Who was eligible to apply for VITEL?
Eligibility was intentionally narrow. Only organizations that were already funded in FY 2013 under the Targeted Capacity Expansion (TCE) Substance Abuse Treatment for Racial/Ethnic Minority Women at High Risk for HIV/AIDS program (the TCE HIV Minority Women cohort; original announcement TI 13 011) could apply.
Why was eligibility limited to the FY 2013 TCE HIV Minority Women grantees?
SAMHSA limited eligibility to those grantees because they already served the population most affected by the intersecting issues VITEL targets and because they already had the infrastructure, partnerships, and clinical capacity to implement IPV screening rapidly without a long start-up period or a break in services.
What population is the supplement ultimately designed to serve?
VITEL builds on the underlying TCE HIV Minority Women program population: African American, Hispanic/Latina, and other racial/ethnic minority women ages 18 and older who have SUDs and/or co-occurring substance use and mental disorders and who are living with HIV/AIDS or at risk for HIV/AIDS.
Does the target population include women of different sexual orientations?
Yes. The underlying program explicitly encompassed women across sexual orientations, including heterosexual, lesbian, and bisexual women.
Does the target population include women who were previously incarcerated?
Yes. The underlying program explicitly included women who were previously incarcerated.
Are significant others included in the population of focus?
Yes. The underlying program explicitly encompassed previously incarcerated women and their significant others.
What are the overarching goals of the VITEL supplement?
The program listed five overarching goals:
- Reduce IPV through screening and referrals.
- Reduce risky behaviors that contribute to new HIV infections and substance use disorders.
- Increase access to care and improve health outcomes for people living with HIV and AIDS.
- Reduce HIV-related health disparities linked to IPV by implementing an IPV screening tool.
- Assess the real-world feasibility of integrating IPV screening into behavioral health settings.
Does VITEL include an evaluation or feasibility component?
Yes. One of the stated goals is to assess the real-world feasibility of integrating IPV screening into behavioral health settings, emphasizing system-level learning alongside client-level impact.
How was VITEL funded?
The supplements were funded by the Secretarys Minority AIDS Initiative Fund (SMAIF), reflecting a federal priority of reducing HIV-related disparities and improving outcomes in disproportionately affected communities.
How many awards were expected under this supplement opportunity?
SAMHSA expected to make 5 awards.
What was the estimated total funding available?
The estimated total funding was $350,000.
What was the maximum award amount per recipient?
The award ceiling was $70,000 for the one-year supplement period.
How long was the supplement period of performance?
The supplement provided one year of funding.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement stated for this opportunity.
What is the assistance listing (CFDA) for this opportunity?
The assistance listing was CFDA 93.243, titled Substance Abuse and Mental Health Services Projects of Regional and National Significance.
When was the opportunity posted and when did it close?
The opportunity was posted April 21, 2015, and the application closing date was June 22, 2015.
Is this funding opportunity still open?
No. The opportunity was archived July 22, 2015.
Who was the listed contact for administrative or access issues?
For administrative or access issues related to the full announcement, the listed contact was Eileen Bermudez in SAMHSAs Division of Grants Management.
Browse more opportunities from the same category: Health
Next opportunity: Environmental Health Services Support for Public Health Drinking Water Programs to Reduce Drinking Water Exposures
Previous opportunity: Monarch Joint Venture Program Support
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for TI 15 013
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (TI 15 013) also looked into and applied for these:
| Funding Opportunity |
|---|
| Environmental Health Services Support for Public Health Drinking Water Programs to Reduce Drinking Water Exposures Apply for CDC RFA EH15 1507 Funding Number: CDC RFA EH15 1507 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $134,000 |
| Community Health Projects Related to Contamination at Brownfield/Land Reuse Sites Apply for CDC RFA TS15 1502 Funding Number: CDC RFA TS15 1502 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Tobacco Regulatory Science Small Grant Program for New Investigators (R03) Apply for RFA OD 15 004 Funding Number: RFA OD 15 004 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Characterization of Pro and Anti Geronic Proteins and Peptides (R01) Apply for RFA AG 16 005 Funding Number: RFA AG 16 005 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Preventing Heart Attacks and Strokes in High Need Areas Apply for CDC RFA DP15 1515 Funding Number: CDC RFA DP15 1515 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,150,000 |
| Rural Quality Improvement Technical Assistance Cooperative Agreement Apply for HRSA 15 150 Funding Number: HRSA 15 150 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Innovations for Healthy Living Improving Population Health and Eliminating Health Disparities (R43)/(R44) Apply for RFA MD 15 009 Funding Number: RFA MD 15 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technologies for Improving Population Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 15 008 Funding Number: RFA MD 15 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PPHF 2015 REACH Racial and Ethnic Approaches to Community Health (REACH) financed in part by 2015 Prevention and Public Health Funding Apply for CDC RFA DP14 141902PPHF15 Funding Number: CDC RFA DP14 141902PPHF15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Leader Fellowship Program Apply for CDC RFA PS15 1508 Funding Number: CDC RFA PS15 1508 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Implementation Technical Assistance Center Apply for HRSA 15 130 Funding Number: HRSA 15 130 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Dissemination and Evaluation Center Apply for HRSA 15 030 Funding Number: HRSA 15 030 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Analyses of Human Datasets and Biospecimens to Characterize Aging related Phenotypes Relationships to Circulating Polypeptides and Proteins that Reverse or Accelerate Aging Changes (R01) Apply for RFA AG 16 012 Funding Number: RFA AG 16 012 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| T1 Translational Research Novel Interventions for Prevention and Treatment of Age related Conditions (R21) Apply for PAR 15 190 Funding Number: PAR 15 190 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Consortia for Innovative AIDS Research in Nonhuman Primates (UM1) Apply for RFA AI 15 022 Funding Number: RFA AI 15 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Infrastructure Resource Access (X01) Apply for PAR 15 195 Funding Number: PAR 15 195 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| T2 Translational Research Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21) Apply for PAR 15 191 Funding Number: PAR 15 191 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) Apply for PAR 15 192 Funding Number: PAR 15 192 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) Apply for PAR 15 193 Funding Number: PAR 15 193 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| PPHF 2015 Asian Language Tobacco Quitline financed solely by 2015 Prevention and Public Health Funds Apply for CDC RFA DP15 1503 Funding Number: CDC RFA DP15 1503 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "TI 15 013", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.